101% Original
Lowest Price
Free Shipping

CJC with DAC 5mg

£69

15 products sold in last 15 hours
Selling fast! Over 16 people have in their cart
24 people are viewing this right now
  • Check Mark Estimated Delivery : Up to 4 business days
  • Check Mark Free Shipping: On all orders over £150
  • Visa Card
  • MasterCard
  • American Express
  • Discover Card
  • PayPal
  • Apple Pay
Guaranteed Safe And Secure Checkout

Research Use Only

These products are for laboratory research only and not intended for medical use. They are not FDA-approved to diagnose, treat, cure, or prevent any disease. By purchasing, you certify they will be used solely for research and not for human or animal consumption.

What is the CJC-1295

CJC-1295 provides extended GHRH activity. Researchers often investigate this combination to better understand growth hormone dynamics in controlled models.

CJC-1295 Overview

CJC-1295, a GHRH analog, is associated with sustained increases in growth hormone and IGF-1, supporting repair and recovery.  CJC-1295 supports for improved body composition, recovery, and anti-aging benefits in clinical research.

Teichman S.L. et al. (2006).

History

CJC-1295, a synthetic analog of growth hormone–releasing hormone (GHRH), was developed in the early 2000s to extend the half-life and activity of natural GHRH fragments for research into growth hormone and IGF-1 pathways.

Svensson J. et al. (1998).

CJC-1295 Structure

CAS #: 446036-97-1

Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂

Molecular Weight: 3367.9 g/mol

PubChem ID: 91976842

Research Findings

CJC-1295 has been examined in endocrine, metabolic, regenerative, and systemic models, with research exploring their influence on growth hormone pathways, body composition, tissue recovery, and cellular viability. Studies highlight their role in IGF-1 activity, repair processes, and systemic resilience in preclinical settings.

Key Areas of Research:

• Endocrine: Growth hormone, IGF-1, signaling

• Metabolic: Lipids, lean tissue, glucose balance

• Cellular: Proliferation, repair, recovery

• Systemic: Cardiovascular, viability, healing

Together, these findings suggest broad experimental potential for CJC-1295 and Ipamorelin across multiple biological pathways. By modulating growth hormone signaling, influencing metabolic activity, and supporting cellular and systemic recovery, this combination provides a versatile platform for research into regeneration, resilience, and physiological balance in laboratory models.

Teichman S.L. et al., Journal of Clinical Endocrinology & Metabolism, 2006

References

Teichman S.L. et al. (2006). Prolonged stimulation of GH and IGF-1 secretion by CJC-1295 in healthy adults. J Clin Endocrinol Metab, 91(3):799-805. 

Lapierre S.S. et al. (2006). Sustained GH and IGF-1 responses to CJC-1295 in GHRH knockout mice. Am J Physiol Endocrinol Metab, 291(2):E282-E287.

Svensson J. et al. (1998). Ipamorelin selectively stimulates GH release without affecting cortisol or prolactin. J Clin Endocrinol Metab, 83(9):3094-3101.

Culler M.D. et al. (2002). Pharmacological characterization of ipamorelin, a novel GHRP with GH selectivity. J Endocrinol, 174(2):R1-R6.

Related products